Delivery Order SPE2DB20D1100-SPE2DB24FB3A2

Award Date 4/16/24
Potential Completion Date 4/17/24
Potential Value $2.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the U.S. Department of Defense's Medical Supply Chain agency to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Bupropion HCL XL 300 mg tablets. The firm-fixed-price delivery order, valued at $44,120.07, has an ultimate completion date of April 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,623,056 units of Bupropion XL 300mg tablets. The $1,674.84 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense. The contract has an ultimate completion date of May 17, 2024 and was awarded on May 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a...
This federal contract award, valued at $13,605.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. Amerisourcebergen, a major pharmaceutical distribution company, was awarded this firm-fixed-price delivery order for the supply of 4,564,542,994 units of Bupropion HCl XL 300 mg tablets. The award does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a delivery order for Bupropion HCL XL 150 mg tablets worth $8,900.78. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of 4564340083 - Bupropion HCl XL 150 mg Tablets in 90-count bottles. The $1,061.84 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 22, 2024. Amerisourcebergen also holds a large Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, for the delivery of Bupropion HCL XL 300 mg tablets. The Delivery Order contract, valued at $1,049.56, has a firm fixed price and an ultimate completion date of May 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,876.60, is for the delivery of Bupropion HCL XL 300 mg tablets and is a firm fixed-price delivery order with a completion date of May 1, 2024. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $21,044.34 for 4563775004 - Bupropion HCL XL 300 mg tablets. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD) that provides medical supplies and pharmaceuticals to the military and veterans' healthcare systems. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) with a ceiling value of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,366.13 firm fixed-price delivery order is for the supply of 4,563,851,552 units of Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of March 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $5,673.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4564186178 BUPROPION HCL XL 300 MG TABLET 500S, a generic pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) awarded by...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB3A2
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 4564296657 - Bupropion HCl XL 300 mg Tablets in 500-count bottles. The $2,937.69 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was not set aside for any specific business type.

Generated 7/16/24, 12:52 PM